Intelligence Platform
Patents
Browse 774 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 11633511
Production of immune-response-stimulating aerosols by non-thermal plasma treatment of airb
granted patentUS 11613528
Small molecule inhibitors of shared epitope-calreticulin interactions and methods of use
granted patentUS 11607387
Efficient aqueous encapsulation and controlled release of bioactive agents
granted patentUS 11607414
Small molecule inhibitors of EGFR and PI3K
granted patentUS 11597773
CD6 antibody for treatment of T-cell mediated diseases or disorders
granted patentUS 11597749
Peptide compositions and methods of use
granted patentUS 11590234
Hyperbranched polymers and polyplexes and DNA or RNA delivery systems including the same
granted patentUS 11571389
Delivery devices and methods for making the same
granted patentUS 11571538
Gas delivery devices
granted patentUS 11555041
Bridged bicyclic inhibitors of menin-MLL and methods of use
granted patentUS 11547551
Engineered tendon graft for rotator cuff repair
granted patentUS 11548899
Fused 1,4-oxazepines and related analogs as BET bromodomain inhibitors
granted patentUS 11542248
Methods and compositions for inhibiting the interaction of menin with MLL proteins
granted patentUS 11510996
Covalent polymer-antigen conjugated particles
granted patentUS 11498928
Macrocyclic spiroethers as Mcl-1 inhibitors
granted patentUS 11484591
Chemoprevention using controlled-release formulations of anti-interleukin 6 agents, synthe
granted patentUS 11478571
Synthetic hydrogel carriers for cellular structures, generation of organoids, and treatmen
granted patentUS 11466028
Fused 1,4-oxazepines as BET protein degraders
granted patentUS 11452724
Methods for treating amyotrophic lateral sclerosis
granted patentUS 11439609
Nitric oxide releasing PLGA microspheres for biomedical applications
granted patentUS 11426368
Plasminogen activator inhibitor-1 (PAI-1) inhibitor and method of use
granted patentUS 11413420
Nitric oxide delivery devices
granted patentUS 11406720
Fibroblast growth factor receptor 2-specific peptide reagents and methods
granted patentUS 11390848
Materials and methods for modifying the activity of T cells
granted